Merck ends trial of potential Alzheimer’s drug verubecestat
Year: 2017
Type: other
Source: BMJ
DOI: 10.1136/bmj.j845
Author: Nigel Hawkes
Language: English
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2588859353
